Assessing experts' perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BioMed Central, c2004-
    • Subject Terms:
      Harm Reduction* ; Substance-Related Disorders*/therapy ; Substance-Related Disorders*/prevention & control; Humans ; New York ; Health Priorities ; Drug Overdose/prevention & control ; Attitude of Health Personnel ; Opioid-Related Disorders/prevention & control ; Continuity of Patient Care
    • Abstract:
      Background: Drug overdose is a leading cause of death and opioid-related deaths increased by more than 300% from 2010 to 2020 in New York State. Experts holding a range of senior leadership positions from across New York State were asked to identify the greatest challenges in substance misuse prevention, harm reduction, and treatment continuum of care. Expert input was used to shape funding priorities.
      Method: Individual semi-structured interviews of sixteen experts were conducted in April and May 2023. Experts included academics, medical directors, leaders of substance misuse service agencies, administrators of a state agency, a county mental health commissioner, the president of a pharmacy chain, and a senior vice president of an addiction-related national non-profit. Zoom interviews were conducted individually by an experienced qualitative interviewer and were recorded, transcribed, and coded for content. An initial report, with the results of the interviews organized by thematic content, was reviewed by the research team and emailed to the expert interviewees for feedback.
      Results: The research team identified five major themes: 1. Siloed and fragmented care delivery systems; 2. Need for a skilled workforce; 3. Attitudes towards addiction (stigma); 4. Limitations in treatment access; and 5. Social and drug related environmental factors. Most experts identified challenges in each major theme; over three-quarters identified issues related to siloed and fragmented systems and the need for a skilled workforce. Each expert mentioned more than one theme, three experts mentioned all five themes and six experts mentioned four themes.
      Conclusions: Research, educational, and programmatic agendas should focus on identified topics as a means of improving the lives of patients at risk for or suffering from substance use-related disorders. The results of this project informed funding of pilot interventions designed to address the identified care challenges.
      (© 2024. The Author(s).)
    • References:
      Prog Community Health Partnersh. 2021;15(2):151-160. (PMID: 34248060)
      Implement Sci. 2022 Jan 6;17(1):3. (PMID: 34991638)
      Subst Abus. 2019;40(2):207-213. (PMID: 30689528)
      Adm Policy Ment Health. 2016 Sep;43(5):640-649. (PMID: 26179469)
      BMJ Open. 2019 Jun 11;9(6):e024659. (PMID: 31189671)
      Subst Abuse Treat Prev Policy. 2020 Nov 4;15(1):84. (PMID: 33148283)
      J Subst Abuse Treat. 2021 Jul;126:108341. (PMID: 34116826)
      Subst Abus. 2015;36(1):51-8. (PMID: 25010520)
      Subst Abuse Treat Prev Policy. 2023 Jan 6;18(1):2. (PMID: 36609268)
      Health Aff (Millwood). 2013 Nov;32(11):2005-12. (PMID: 24191093)
      Psychol Trauma. 2020 May;12(4):373-380. (PMID: 31524428)
      J Rural Health. 2022 Jan;38(1):70-76. (PMID: 32613709)
      Subst Abuse Rehabil. 2022 Jan 25;13:1-12. (PMID: 35115860)
      J Psychiatr Ment Health Nurs. 2022 Apr;29(2):307-316. (PMID: 34453870)
      Learn Health Syst. 2019 Feb 05;3(2):e10186. (PMID: 31245604)
      J Rural Health. 2016 Winter;32(1):92-101. (PMID: 26184098)
      Harm Reduct J. 2024 Feb 27;21(1):52. (PMID: 38413972)
      Drug Alcohol Depend. 2013 Jul 1;131(1-2):23-35. (PMID: 23490450)
      Subst Abuse Treat Prev Policy. 2020 Jun 18;15(1):42. (PMID: 32552836)
      AIDS Behav. 2018 Dec;22(12):3892-3896. (PMID: 29909588)
      J Subst Abuse Treat. 2016 Feb;61:47-59. (PMID: 26531892)
      Addict Res Theory. 2008;16(2):149-165. (PMID: 27746709)
      Explor Res Clin Soc Pharm. 2021 Jun 04;2:100029. (PMID: 35481114)
      J Subst Abuse Treat. 2021 Dec;131:108486. (PMID: 34217033)
      Am J Prev Med. 2018 Jun;54(6 Suppl 3):S230-S242. (PMID: 29779547)
      Harm Reduct J. 2024 Feb 27;21(1):53. (PMID: 38413991)
      J Psychoactive Drugs. 2013 Jan-Mar;45(1):17-27. (PMID: 23662328)
    • Contributed Indexing:
      Keywords: Challenges; Harm reduction; Prevention; Substance misuse; Treatment
    • Publication Date:
      Date Created: 20240714 Date Completed: 20240714 Latest Revision: 20240717
    • Publication Date:
      20240717
    • Accession Number:
      PMC11247824
    • Accession Number:
      10.1186/s12954-024-01045-3
    • Accession Number:
      39004729